398 related articles for article (PubMed ID: 17258320)
1. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.
Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
Ophthalmology; 2007 Apr; 114(4):787-93. PubMed ID: 17210182
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Sugar EA; Jabs DA; Ahuja A; Thorne JE; Danis RP; Meinert CL;
Am J Ophthalmol; 2012 Jun; 153(6):1016-24.e5. PubMed ID: 22310076
[TBL] [Abstract][Full Text] [Related]
5. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD
Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839
[TBL] [Abstract][Full Text] [Related]
7. Visual field loss in patients with cytomegalovirus retinitis.
Thorne JE; Van Natta ML; Jabs DA; Duncan JL; Srivastava SK;
Ophthalmology; 2011 May; 118(5):895-901. PubMed ID: 21146225
[TBL] [Abstract][Full Text] [Related]
8. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2232-9. PubMed ID: 15582079
[TBL] [Abstract][Full Text] [Related]
9. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
Ophthalmology; 2004 Dec; 111(12):2224-31. PubMed ID: 15582078
[TBL] [Abstract][Full Text] [Related]
10. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
11. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
Jabs DA; Ahuja A; Van Natta M; Lyon A; Srivastava S; Gangaputra S;
Ophthalmology; 2010 Nov; 117(11):2152-61.e1-2. PubMed ID: 20673591
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
[TBL] [Abstract][Full Text] [Related]
13. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
[TBL] [Abstract][Full Text] [Related]
14. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
Jabs DA; Ahuja A; Van Natta ML; Lyon AT; Yeh S; Danis R;
Ophthalmology; 2015 Jul; 122(7):1452-63. PubMed ID: 25892019
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
Holbrook JT; Colvin R; van Natta ML; Thorne JE; Bardsley M; Jabs DA;
Am J Ophthalmol; 2011 Oct; 152(4):628-637.e1. PubMed ID: 21742304
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
[TBL] [Abstract][Full Text] [Related]
17. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR
Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of cytomegalovirus retinitis in HIV-infected patients with low CD4 lymphocyte counts in Vietnam.
Colby DJ; Vo DQ; Teoh SC; Tam NT; Liem NT; Lu D; Nguyen TT; Cosimi L; Pollack T; Libman H
Int J STD AIDS; 2014 Jun; 25(7):516-22. PubMed ID: 24327723
[TBL] [Abstract][Full Text] [Related]
19. Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.
Gangaputra S; Drye L; Vaidya V; Thorne JE; Jabs DA; Lyon AT;
Am J Ophthalmol; 2013 Feb; 155(2):206-212.e5. PubMed ID: 23068916
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy.
Song MK; Schrier RD; Smith IL; Plummer DJ; Freeman WR
Retina; 2002 Jun; 22(3):262-7. PubMed ID: 12055457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
